A股異動 | 中兵紅箭(000519.SZ)跌超7% 2019年度公司增收不增利
格隆匯4月28日丨中兵紅箭(000519.SZ)大跌7.58%,報8.29元,暫成交7.79億元,最新總市值115億元。中兵紅箭昨日公告,一季度實現營業收入53.22億元,同比增長7.43%;歸屬於上市公司股東的淨利潤2.55億元,同比下降26.49%。2019年度公司增收不增利。另外,此前一季度淨利預降69.63%-75.16%。值得一提的是,在超硬材料業務板塊方面,大顆粒寶石級培育鑽石實現了批量供應市場,成為公司新的經濟增長點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.